258 related articles for article (PubMed ID: 24853933)
1. Blood-brain barrier: a dual life of MFSD2A?
Zhao Z; Zlokovic BV
Neuron; 2014 May; 82(4):728-30. PubMed ID: 24853933
[TBL] [Abstract][Full Text] [Related]
2. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid.
Nguyen LN; Ma D; Shui G; Wong P; Cazenave-Gassiot A; Zhang X; Wenk MR; Goh EL; Silver DL
Nature; 2014 May; 509(7501):503-6. PubMed ID: 24828044
[TBL] [Abstract][Full Text] [Related]
3. Physiology: Double function at the blood-brain barrier.
Betsholtz C
Nature; 2014 May; 509(7501):432-3. PubMed ID: 24828036
[No Abstract] [Full Text] [Related]
4. Mfsd2a Is a Transporter for the Essential ω-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development.
Wong BH; Chan JP; Cazenave-Gassiot A; Poh RW; Foo JC; Galam DL; Ghosh S; Nguyen LN; Barathi VA; Yeo SW; Luu CD; Wenk MR; Silver DL
J Biol Chem; 2016 May; 291(20):10501-14. PubMed ID: 27008858
[TBL] [Abstract][Full Text] [Related]
5. The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain.
Chan JP; Wong BH; Chin CF; Galam DLA; Foo JC; Wong LC; Ghosh S; Wenk MR; Cazenave-Gassiot A; Silver DL
PLoS Biol; 2018 Aug; 16(8):e2006443. PubMed ID: 30074985
[TBL] [Abstract][Full Text] [Related]
6. Metastatic Brain Tumors Disrupt the Blood-Brain Barrier and Alter Lipid Metabolism by Inhibiting Expression of the Endothelial Cell Fatty Acid Transporter Mfsd2a.
Tiwary S; Morales JE; Kwiatkowski SC; Lang FF; Rao G; McCarty JH
Sci Rep; 2018 May; 8(1):8267. PubMed ID: 29844613
[TBL] [Abstract][Full Text] [Related]
7. Aging decreases docosahexaenoic acid transport across the blood-brain barrier in C57BL/6J mice.
Iwao T; Takata F; Matsumoto J; Aridome H; Yasunaga M; Yokoya M; Kataoka Y; Dohgu S
PLoS One; 2023; 18(2):e0281946. PubMed ID: 36795730
[TBL] [Abstract][Full Text] [Related]
8. Mfsd2a is critical for the formation and function of the blood-brain barrier.
Ben-Zvi A; Lacoste B; Kur E; Andreone BJ; Mayshar Y; Yan H; Gu C
Nature; 2014 May; 509(7501):507-11. PubMed ID: 24828040
[TBL] [Abstract][Full Text] [Related]
9. Mfsd2a: A Physiologically Important Lysolipid Transporter in the Brain and Eye.
Wong BH; Silver DL
Adv Exp Med Biol; 2020; 1276():223-234. PubMed ID: 32705603
[TBL] [Abstract][Full Text] [Related]
10. Lipid flipping in the omega-3 fatty-acid transporter.
Nguyen C; Lei HT; Lai LTF; Gallenito MJ; Mu X; Matthies D; Gonen T
Nat Commun; 2023 May; 14(1):2571. PubMed ID: 37156797
[TBL] [Abstract][Full Text] [Related]
11. Mfsd2a attenuated hypoxic-ischemic brain damage via protection of the blood-brain barrier in mfat-1 transgenic mice.
Li X; Zhang Y; Chang J; Zhang C; Li L; Dai Y; Yang H; Wang Y
Cell Mol Life Sci; 2023 Feb; 80(3):71. PubMed ID: 36820986
[TBL] [Abstract][Full Text] [Related]
12. Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid.
Pan Y; Scanlon MJ; Owada Y; Yamamoto Y; Porter CJ; Nicolazzo JA
Mol Pharm; 2015 Dec; 12(12):4375-85. PubMed ID: 26455443
[TBL] [Abstract][Full Text] [Related]
13. Dietary docosahexaenoic acid supplementation enhances expression of fatty acid-binding protein 5 at the blood-brain barrier and brain docosahexaenoic acid levels.
Pan Y; Morris ER; Scanlon MJ; Marriott PJ; Porter CJH; Nicolazzo JA
J Neurochem; 2018 Jul; 146(2):186-197. PubMed ID: 29582413
[TBL] [Abstract][Full Text] [Related]
14. Homozygous mutation in MFSD2A, encoding a lysolipid transporter for docosahexanoic acid, is associated with microcephaly and hypomyelination.
Harel T; Quek DQY; Wong BH; Cazenave-Gassiot A; Wenk MR; Fan H; Berger I; Shmueli D; Shaag A; Silver DL; Elpeleg O; Edvardson S
Neurogenetics; 2018 Dec; 19(4):227-235. PubMed ID: 30043326
[TBL] [Abstract][Full Text] [Related]
15. Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier.
Wang JZ; Xiao N; Zhang YZ; Zhao CX; Guo XH; Lu LM
Pharmacol Res; 2016 Feb; 104():124-31. PubMed ID: 26747400
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone Increases Blood-Brain Barrier Expression of Fatty Acid-Binding Protein 5 and Docosahexaenoic Acid Trafficking into the Brain.
Low YL; Jin L; Morris ER; Pan Y; Nicolazzo JA
Mol Pharm; 2020 Mar; 17(3):873-884. PubMed ID: 31944767
[TBL] [Abstract][Full Text] [Related]
17. Mfsd2a (Major Facilitator Superfamily Domain Containing 2a) Attenuates Intracerebral Hemorrhage-Induced Blood-Brain Barrier Disruption by Inhibiting Vesicular Transcytosis.
Yang YR; Xiong XY; Liu J; Wu LR; Zhong Q; Zhou K; Meng ZY; Liu L; Wang FX; Gong QW; Liao MF; Duan CM; Li J; Yang MH; Zhang Q; Gong CX; Yang QW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724654
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of fatty acid transport and binding proteins in the blood-brain barrier and the cerebral cortex of the rat: differences across development and with different DHA brain status.
Pélerin H; Jouin M; Lallemand MS; Alessandri JM; Cunnane SC; Langelier B; Guesnet P
Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):213-20. PubMed ID: 25123062
[TBL] [Abstract][Full Text] [Related]
19. Esterification of Docosahexaenoic Acid Enhances Its Transport to the Brain and Its Potential Therapeutic Use in Brain Diseases.
Lo Van A; Bernoud-Hubac N; Lagarde M
Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364810
[TBL] [Abstract][Full Text] [Related]
20. Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function.
Pan Y; Short JL; Choy KH; Zeng AX; Marriott PJ; Owada Y; Scanlon MJ; Porter CJ; Nicolazzo JA
J Neurosci; 2016 Nov; 36(46):11755-11767. PubMed ID: 27852782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
